8-K: Paramount Skydance Shifts to NYSE, Details Warrant Distribution
Current Report (Form 8-K)
Paramount Skydance Corporation announced its voluntary delisting from Nasdaq to transfer its Class B Common Stock listing to the New York Stock Exchange, alongside detailed plans for a warrant distribution contingent on its acquisition of Warner Bros. Discovery.
Summary
- Paramount Skydance Corporation is transferring its Class B Common Stock listing from Nasdaq to the New York Stock Exchange (NYSE), with trading expected to begin on the NYSE around October 6, 2026.
- The company has set a record date of October 5, 2026, for a previously announced distribution of warrants to purchase Class B Common Stock.
- Approximately 470 million warrants are expected to be distributed on or about October 13, 2026.
- The warrant distribution is contingent on the closing of the acquisition of Warner Bros. Discovery, Inc. (WBD Merger), which has uncertain timing.
- Eligible holders will receive one warrant for each share of Class B Common Stock held, excluding certain 'Restricted Holders' and Paramount Global 401(k) Plan holders.
- The exercise price for the warrants will be determined based on the average daily volume-weighted average price of the Class B Common Stock for a 20-day period prior to the WBD Merger closing, with a maximum of $16.02 and a minimum of $12.00.
- Warrants will expire ten years after the issue date, but may expire earlier if the Class B Common Stock price exceeds $30.00 for a specified period.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly positive development, primarily due to the strategic stock exchange transfer and the detailed, albeit conditional, warrant distribution plan. The uncertainty surrounding the WBD merger introduces a significant caveat.
Positives
- Transferring to the NYSE may provide enhanced visibility and access to a broader investor base.
- The warrant distribution offers eligible shareholders potential upside participation in future stock appreciation.
- The warrants are not dilutive at the time of issuance, as they only convert to shares upon exercise.
- The exercise price range ($12.00 $16.02) provides a defined potential entry point for future share acquisition.
- The company expects to receive significant capital if warrants are exercised, potentially up to $5.6 billion based on assumptions.
Negatives
- The warrant distribution is entirely contingent on the successful closing of the Warner Bros. Discovery merger, which faces uncertain timing and closing conditions.
- Certain significant holders, including affiliates of Lawrence J. Ellison and RedBird Capital Partners, are excluded from receiving warrants.
- Paramount Global 401(k) Plan holders will receive shares of Class B Common Stock instead of warrants, subject to separate arrangements.
- There is no guarantee that an active trading market for the warrants will develop or be sustained.
- The exercise price could be higher than the market price of Class B Common Stock, rendering the warrants worthless if not exercised or sold before expiration.
Risks
- The WBD Merger may not be completed due to unsatisfied closing conditions or other factors.
- The timing of the WBD Merger closing is uncertain, which directly impacts the warrant distribution timeline.
- The company's dual-class capital structure and concentrated ownership may affect the stock price.
- The Class B Common Stock lacks voting rights.
- The warrants could expire worthless if not exercised or sold before their expiration date.
- The exercise window for warrants could be shortened if the company designates an early expiration date.
- Volatility in the price of Class B Common Stock and any warrants poses a risk to holders.
Future Outlook
The company's future outlook is heavily dependent on the successful completion of the WBD Merger. The warrant distribution and NYSE listing are planned, but contingent on merger closing. The exercise price of warrants is tied to the WBD Merger's closing timeline, and warrants have a ten-year expiration, with a potential for early expiration based on stock performance.
Management Comments
- The warrants are intended to provide eligible holders of the Class B Common Stock with the opportunity to purchase shares of Class B Common Stock on similar terms to those offered to the parties to the Equity Syndication and to participate in any future appreciation in the value of the Class B Common Stock, or alternatively to monetize the value of the warrants directly by selling them.
- The Company expects to use proceeds from warrant exercises for general corporate purposes.
Industry Context
StockSavvy.ai notes that the shift from Nasdaq to NYSE is a common strategic move for companies seeking to enhance their profile or access different investor pools. The detailed warrant distribution plan, tied to a significant acquisition, is a complex financial instrument designed to incentivize shareholders and potentially raise substantial capital, reflecting a proactive approach to financing large corporate transactions in the media and entertainment sector.
Comparison to Industry Standards
- The transfer of listing from Nasdaq to NYSE is a standard practice for mature companies aiming for broader market access and prestige, similar to moves made by other large-cap technology and media firms.
- Warrant distributions as a form of shareholder incentive or financing mechanism are not uncommon, particularly in the context of mergers and acquisitions. However, the scale of this potential $5.6 billion capital raise is significant and aligns with the substantial financial commitments required for major industry consolidations.
- The structure of the warrants, with a defined exercise price range and potential for early expiration, is consistent with market practices for such instruments.
Related Party Transactions
- Certain 'Restricted Holders' (affiliates of Lawrence J. Ellison, David F. Ellison, Gerald J. Cardinale, The Lawrence J. Ellison Revocable Trust, and RedBird Capital Partners Fund IV) are excluded from receiving warrants.
- Paramount Global 401(k) Plan Holders and wholly owned subsidiaries holding Class B Common Stock are also excluded from the warrant distribution.
Stakeholder Impact
- Shareholders (excluding Restricted Holders and 401(k) Plan holders) will receive warrants, offering potential upside but also introducing complexity and potential dilution upon exercise.
- The transfer to NYSE may impact trading liquidity and investor perception.
- Creditors and other stakeholders will be monitoring the WBD Merger's outcome and the company's financial health, especially given the potential for significant capital infusion or dilution.
Next Steps
- Monitor the closing of the WBD Merger.
- Await further announcements regarding any changes to the Record Date or Issue Date.
- Observe the trading of Class B Common Stock on the NYSE starting October 6, 2026.
- Prepare for the warrant distribution on or about October 13, 2026.
- Review the official Warrant Agreement to be filed with the SEC.
Key Dates
| Date | Description |
|---|---|
| 2026-04-07 | Initial announcement of intent to distribute warrants. |
| 2026-09-25 | Date of the Form 8-K filing; Board authorization for listing transfer and determination of warrant distribution. |
| 2026-10-05 | Record Date for warrant distribution (close of business). |
| 2026-10-05 | Expected end of trading on Nasdaq. |
| 2026-10-06 | Expected start of trading on NYSE. |
| 2026-10-13 | Expected Issue Date for warrant distribution. |
| 2026-10-14 | Expected Ex-Dividend Date for warrant distribution. |
| 2036-10-13 | Scheduled expiration date for warrants (ten years after Issue Date). |
Recommendation
holdThe filing presents a mixed picture. The strategic move to the NYSE is positive, and the warrant distribution offers potential upside. However, the significant contingency on the WBD Merger, coupled with the exclusion of key holders and the inherent risks of warrants, warrants a cautious 'hold' until the merger's outcome and warrant mechanics become clearer.
Keywords
warrant distribution, stock exchange transfer, NYSE listing, Nasdaq delisting, merger contingency, exercise price, shareholder rights, capital raise
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.